Search - tctmd.com

Displaying 101 - 120 of 735

Sort: Relevancy | Date

Erectile Dysfunction Drugs Don’t Mix Well With Nitrates After MI, PCI

News Daily News

Erectile Dysfunction Drugs Don’t Mix Well With Nitrates After MI, PCI

January 16, 2024

HeartMate 3 Use Postapproval Is Soaring—and Equitably, New Numbers Show

News Daily News

HeartMate 3 Use Postapproval Is Soaring—and Equitably, New Numbers Show

Yael L. Maxwell

January 10, 2024

High-Sensitivity Troponins Improve HEART Pathway in Chest Pain Workup

News Daily News

High-Sensitivity Troponins Improve HEART Pathway in Chest Pain Workup

Yael L. Maxwell

December 21, 2023

Aspirin Use Tied to Slower AAA Progression

News Daily News

Aspirin Use Tied to Slower AAA Progression

December 20, 2023

FDA Clears AI-ECG Screening Tools for CV Care: What’s Next Is Up for Grabs

News Features

FDA Clears AI-ECG Screening Tools for CV Care: What’s Next Is Up for Grabs

Yael L. Maxwell

December 14, 2023

Daily Texts Boost Self-care in HFrEF but Don’t Impact Outcomes

News Daily News

Daily Texts Boost Self-care in HFrEF but Don’t Impact Outcomes

December 08, 2023

TCT Abstract Ranking Reveals Global CVD Research Hot Spots

News Daily News

TCT Abstract Ranking Reveals Global CVD Research Hot Spots

November 21, 2023

Large, Sustained Reductions in Lp(a) With Lepodisiran in Phase I Study

News Conference News AHA 2023

Large, Sustained Reductions in Lp(a) With Lepodisiran in Phase I Study

Michael O'Riordan

November 13, 2023

New PCSK9 Inhibitor Halves LDL: Will Protracted Dosing Make a Difference?

News Conference News AHA 2023

New PCSK9 Inhibitor Halves LDL: Will Protracted Dosing Make a Difference?

November 13, 2023

AZALEA-TIMI 71: Abelacimab Slashes Bleeds vs Rivaroxaban in AF, but Stroke Impact Unclear

News Conference News AHA 2023

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

November 12, 2023

Gene Editing Shuts Off PCSK9 to Lower LDL in HeFH: Heart-1

News Conference News AHA 2023

Gene Editing Shuts Off PCSK9 to Lower LDL in HeFH

November 12, 2023

ARTESiA: Apixaban Lowers Stroke Risk in Subclinical AF

News Conference News AHA 2023

ARTESiA: Apixaban Lowers Stroke Risk in Subclinical AF

November 12, 2023

Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics

News Conference News AHA 2023

Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics

November 11, 2023

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

News Conference News AHA 2023

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

November 11, 2023

FDA Approves Paradise Renal Denervation System: What Comes Next?

News Daily News

FDA Approves Paradise Renal Denervation System: What Comes Next?

November 08, 2023

What’s Going to Be Hot at AHA 2023

News Opinion Editor's Corner AHA 2023

What’s Going to Be Hot at AHA 2023

November 07, 2023

‘Dire’ Lack of Vascular Care in Underserved Areas Needs Creativity, Compassion

News Conference News VIVA 2023

‘Dire’ Lack of Vascular Care in Underserved Areas Needs Creativity, Compassion

November 03, 2023

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

News Conference News TCT 2023

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

Yael L. Maxwell

November 02, 2023

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

News Conference News TCT 2023

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

Yael L. Maxwell

October 30, 2023

ANTHEM-HFrEF Fails to Show Benefit of Vagal Nerve Stimulation Over GDMT

News Conference News HFSA 2023

ANTHEM-HFrEF Fails to Show Benefit of Vagal Nerve Stimulation Over GDMT

Yael L. Maxwell

October 16, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.